Left Cardiac Sympathetic Denervation In The Management Of High-Risk Patients Affected By The Long-Qt Syndrome

peter j schwartz,silvia g priori,marina cerrone,carla spazzolini,attilio odero,carlo napolitano,raffaella bloise,gaetano m de ferrari,catherine klersy,arthur j moss,wojciech zareba,jennifer l robinson,w jackson hall,Paul A Brink,lauri toivonen,andrew e epstein,cuilan li,dayi hu
DOI: https://doi.org/10.1161/01.CIR.0000125523.14403.1E
IF: 37.8
2004-01-01
Circulation
Abstract:Background - The management of long-QT syndrome (LQTS) patients who continue to have cardiac events (CEs) despite beta-blockers is complex. We assessed the long-term efficacy of left cardiac sympathetic denervation (LCSD) in a group of high-risk patients.Methods and Results - We identified 147 LQTS patients who underwent LCSD. Their QT interval was very prolonged (QTc, 543 +/- 65 ms); 99% were symptomatic; 48% had a cardiac arrest; and 75% of those treated with beta-blockers remained symptomatic. The average follow-up periods between first CE and LCSD and post-LCSD were 4.6 and 7.8 years, respectively. After LCSD, 46% remained asymptomatic. Syncope occurred in 31%, aborted cardiac arrest in 16%, and sudden death in 7%. The mean yearly number of CEs per patient dropped by 91% ( P < 0.001). Among 74 patients with only syncope before LCSD, all types of CEs decreased significantly as in the entire group, and a post-LCSD QTc < 500 ms predicted very low risk. The percentage of patients with > 5 CEs declined from 55% to 8% ( P < 0.001). In 5 patients with preoperative implantable defibrillator and multiple discharges, the post-LCSD count of shocks decreased by 95% ( P = 0.02) from a median number of 25 to 0 per patient. Among 51 genotyped patients, LCSD appeared more effective in LQT1 and LQT3 patients.Conclusions - LCSD is associated with a significant reduction in the incidence of aborted cardiac arrest and syncope in high-risk LQTS patients when compared with pre-LCSD events. However, LCSD is not entirely effective in preventing cardiac events including sudden cardiac death during long-term follow-up. LCSD should be considered in patients with recurrent syncope despite beta-blockade and in patients who experience arrhythmia storms with an implanted defibrillator.
What problem does this paper attempt to address?